About the BIO CEO & Investor Conference

  • Recommend
  • Tweet
  • Print
  • Email

February 8-9, 2016 | The Waldorf Astoria New York
Now in its eighteenth year, the BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded and select private biotech companies.

Why Investors Attend

  • Hear from and meet one-on-one with management from the top biotechnology companies.
  • Evaluate fresh investment opportunities including compatible, complementary and competitive companies.
  • Attend candid panel discussions with leading clinical experts and company experts on the latest therapies and technologies in development.
  • Get a ‘big picture’ overview of the industry and the issues affecting investments now and in the future.

Why Companies Attend

  • Present company story to an audience of target investors.
  • Meet one-on-one with new and current investors, analysts, investment bankers and other potential corporate partners.
  • Hear candid panel discussions and keynotes by veteran investment and company executives.
  • Network with peers, investors and potential partners attending the conference.
  • Get the pulse on the current and proposed investment trends in biotechnology.

2015 Statistics

  • 1,400+ registrants
  • 622 registered investors 
  • 2,200 partnering meetings scheduled, a 21% increase over last year!
  • 52% of attendees were executives
  • 377 companies in attendance


2015 Attendees by Seniority 








2015 Attendees by Company Type


2015 Attendees by Therapeutic Focus


Total Partnering Meetings by Year